Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The unique and proprietary technology owned by Dermaliq, called hyliQ, is designed to allow cutaneous drug delivery with u...
Use this information to figure out if this company is an ideal customer for you.
1201 North Market Street
Wilmington, 19801
Dermaliq Therapeutics Inc.'s CEO is Frank Löscher Rer Nat
Dermaliq Therapeutics Inc.'s HQ is located at 1201 North Market Street, Wilmington
Dermaliq Therapeutics Inc.'s official website is dermaliq.com
Dermaliq Therapeutics Inc.'s revenue is $1M - $5M
Dermaliq Therapeutics Inc. has 51 - 200 employees
Dermaliq Therapeutics Inc. is in the industry of: Pharmaceuticals